![全球援助仪式分析报告-培训课件外文版2024.5_第1页](http://file4.renrendoc.com/view4/M02/0B/17/wKhkGGZ_vMmAQRn4AABiKTVrUwE032.jpg)
![全球援助仪式分析报告-培训课件外文版2024.5_第2页](http://file4.renrendoc.com/view4/M02/0B/17/wKhkGGZ_vMmAQRn4AABiKTVrUwE0322.jpg)
![全球援助仪式分析报告-培训课件外文版2024.5_第3页](http://file4.renrendoc.com/view4/M02/0B/17/wKhkGGZ_vMmAQRn4AABiKTVrUwE0323.jpg)
![全球援助仪式分析报告-培训课件外文版2024.5_第4页](http://file4.renrendoc.com/view4/M02/0B/17/wKhkGGZ_vMmAQRn4AABiKTVrUwE0324.jpg)
![全球援助仪式分析报告-培训课件外文版2024.5_第5页](http://file4.renrendoc.com/view4/M02/0B/17/wKhkGGZ_vMmAQRn4AABiKTVrUwE0325.jpg)
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
COMPANIES
&
PRODUCTSRiteAidCHAPTER
01MarketoverviewRevenueofthepharmaciesanddrugstoresindustryintheUnitedStatesfrom2009to2022(inbillionU.S.dollars)Revenueofthepharmacies&drugstoresindustryintheU.S.2009-2022400350351.6338.2318.86312.61303.45296.96289.8230025020015010050283.92272.88266.14261.1259.67261.4258.240200920102011201220132014201520162017201820192020202120223Description:TherevenueoftheU.S.pharmaciesanddrugstoresindustrywasestimatedtovalueabout318.86billionU.S.dollarsin2020.Theindustrywasprojectedtoreachavalueof351.6billionU.S.dollarsby2022.
ReadmoreNote(s):UnitedStates;2022Source(s):IBISWorldAverageannualexpenditureonprescriptiondrugsperconsumerunitintheUnitedStatesfrom2007to2022(inU.S.dollars)U.S.householdexpenditureonprescriptiondrugs2007-2022400366.4361.72359.32355.73350.07344.56341.3835030025020015010050329.67321.55296.04285.67
284.69269.85267.69263.18259.19020072008200920102011201220132014201520162017201820192020202120224Description:ThisstatisticshowstheaverageannualexpenditureonprescriptiondrugsperconsumerunitintheUnitedStatesfrom2007to2022.In2022,thecountry'saverageexpenditureonprescriptiondrugsamountedtosome341U.S.dollarsperconsumerunit,anincreaseofmorethan70dollarscomparedtothepreviousyear.ReadmoreNote(s):UnitedStatesSource(s):BureauofLaborStatisticsPharmacyanddrugstoresalesintheUnitedStatesfrom1992to2021(inbillionU.S.dollars)PharmacyanddrugstoresalesintheU.S.1992-2021350300250200150100501992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021Year5Description:ThistimelinedepictspharmacyanddrugstoresalesintheUnitedStatesfrom1992to2021.In2021,U.S.pharmacyanddrugstoresalesamountedtoabout324.6billionU.S.dollars.
ReadmoreNote(s):UnitedStates;1992to2021Source(s):USCensusBureauAverageannualexpenditureonnonprescriptiondrugsperconsumerunitintheUnitedStatesfrom2007to2022(inU.S.dollars)U.S.householdexpenditureonnonprescriptiondrugs2007-2022155145135142.43133.7125.4412511510595120.9120.02115.74111.6799.6699.5797.49201296.26201392.57201189.56201086.62200881.7420098575.4756520072014201520162017201820192020202120226Description:ThisstatisticshowstheaverageannualexpenditureonnonprescriptiondrugsperconsumerunitintheUnitedStatesfrom2007to2022.In2022,thecountry'saverageexpenditureonnonprescriptiondrugsamountedtoover140U.S.dollarsperconsumerunit.ReadmoreNote(s):UnitedStates;2007to2022Source(s):BureauofLaborStatisticsConsumerpriceindexforprescriptionandnonprescriptiondrugsintheU.S.from1960to2022U.S.consumerpriceindex:prescriptionandnonprescriptiondrugs1960-2022PrescriptiondrugsNonprescriptiondrugs*469.8600537.9534.9525.4
522.1525.2
525.3511.2481.1500441.6437.9429.8412.8396.5379.94003002001000369.2156.8349285.4235181.7120.6149.5
151.7140.51009999.1
99.7
98.4
98.39797.2
96.8
97.396.8
10296.595.972.55447.41960
1970
1980
1990
1995
2000
2005
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
20227/statistics/187253/us-consumer-price-index-for-prescription-drugs-from-1960AsofDecember2022,theCPIforprescriptiondrugswasat535comparedtotheperiodfrom1982to1984(=100).ThisstatisticshowstheconsumerpriceindexforprescriptionandnonprescriptiondrugsintheUnitedStatesfrom1960to2022.
ReadmoreNote(s):UnitedStatesSource(s):BureauofLaborStatistics;USDepartmentofLaborCHAPTER
02MainplayersLeadingpharmaciesintheUnitedStatesin2022,basedonprescriptionrevenue(inbillionU.S.dollars)LeadingpharmaciesintheU.S.2022,basedonprescriptionrevenueRevenueinbillionU.S.dollars020406080100120140160CVSHealthCorporation*WalgreensBootsAllianceCigna(Evernorth/ExpressScripts)UnitedHealthGroup(OptumRx)WalmartStores,Inc.**TheKrogerCompanyRiteAidCorporation140.185.261.337.824.116.812.9Humana(CenterWell)AlbertsonsCompaniesPublix9.76.46.1CostcoWholesaleCorporationBrightSpringHealthServicesCentene(EnvolveHealth)AholdDelhaize32.82.72.72.4CarepathRx9Description:ThisstatisticshowstheleadingpharmaciesintheUnitedStatesin2022,basedonprescriptionrevenue.Inthatyear,CVSHealthCorporation'sprescriptionrevenueintheUnitedStatesamountedtoanestimated140billionU.S.dollars.
ReadmoreNote(s):UnitedStates;*Retailpharmacyprescriptionrevenue81.1billionU.S.dollars;Pharmacyservicesrevenue59billionU.S.dollars.**IncludesWalmartandSam'sClubstores.
ReadmoreSource(s):DrugChannelsInstituteTopU.S.pharmaciesrankedbyprescriptiondrugsmarketsharein2022U.S.pharmaciesrankedbyprescriptiondrugsmarketshare2022Marketshare0%5%10%15%20%25%30%CVShealthCorporation*WalgreensBootsAlliance(RetailPharmacyUSA)Cigna(Evernorth/ExpressScripts,Inc.)**UnitedHealthGroup(OptumRx)WalmartStores,Inc.25.6%15.5%11.2%6.9%4.4%TheKrogerCompanyRiteAidCorporationHumana(CenterWell)AlbertsonsCompanies3.1%2.3%1.8%1.2%1.1%0.6%PublixCostcoWholesaleCorporationBrightSpringHealthServicesCentene(EnvolveHealth)AholdDelhaize0.5%0.5%0.5%0.4%CarepathRx10Description:ThetopU.S.pharmacyin2022bymarketsharebasedonprescriptiondrugrevenuewasCVSHealthCorporation,followedbyWalgreensBootsAlliance.CVSHealthheldover25percentoftheprescriptiondrugmarketrevenueatthattime.AsignificantincreaseinmarketsharewasreportedforCignaachievedthroughtheacquisitionofpharmacybenefitmanagerExpressScriptsinAugust2018.Beforethat,Cignawasmainlyactiveintheinsurancebusinessandrelatedproductsand[...]
ReadmoreNote(s):UnitedStatesSource(s):DrugChannelsInstituteLeadingdrugstoresintheUnitedStatesin2022,basedonretailsales(inbillionU.S.dollars)LeadingdrugstoresintheU.S.2022,basedonretailsalesRetailsalesinbillionU.S.dollars40
6002080100120140WalgreensBootAllianceCVSHealthCorporationRiteAid116.1106.5917.57Hy-Vee12.44HealthMartSystems11.911Description:ThisrankingshowstheleadingdrugstoresintheUnitedStates,basedonworldwideretailsalesintheyearof2022.Inthatyear,WalgreensBootAlliancewastheleadingdrugstoreintheUnitedStateswithretailsalesaddinguptoabout116billionU.S.dollars.ReadmoreNote(s):UnitedStates;2023Source(s):Kantar;NationalRetailFederationNumberofstoresoftheleadingdrugstoresintheUnitedStatesin2022NumberofstoresoftheleadingdrugstoresintheU.S.202212,0009,72810,0008,0006,0004,0002,00008,7855,3264,7342,8562,3502,309574371329CVSHealthWalgreensBootsAllianceWalmartHealthMart
TheKrogerCo.Good
NeighborSystem
PharmacyCompanyRiteAidCostcoWakefern/ShopRiteHy-Vee12Description:ThisstatisticshowsthenumberofstoresoftheleadingdrugstoresintheUnitedStatesin2022,byformat.Inthatyear,RiteAidhadatotalof2,309storesintheUnitedStates.ReadmoreNote(s):UnitedStates;2022Source(s):NationalRetailFederationLeadingonlinepharmaciesrankedbybrandawarenessintheUnitedStatesin2022Mostwell-knownonlinepharmaciesintheUnitedStates2022Shareofrespondents40%
50%0%10%20%30%60%70%80%90%100%WalgreensCVSpharmacy88%86%RiteAid77%HealthWAllegroMedicalNorthWestPCanadaPInstaflex20%18%16%16%15%CanadaPharmacyOnlineLloydsPharmacy15%15%15%CanadianPharmacyWorldMEDICALMEGA14%14%13Description:With88%brandawarenessisWalgreensthemostpopularonlinepharmacyintheU.S.SecondonthislistisCVSpharmacywhichisrecognizedby84%ofinternetrespondentsintheUnitedStates,followedbyanother77%consumerswhoareawareofRiteAid.Hcomesinfourthonthislist,followedbyAllegroMedicalandNorthWestP.ReadmoreNote(s):UnitedStates;JunetoJuly2022;1244respondents;18to64yearsSource(s):ConsumerInsightsLeadingbeautyandhealthonlineshopsrankedbybrandawarenessintheUnitedStatesin2022Mostwell-knownbeautyandhealthonlineshopsintheUnitedStates2022Shareofrespondents0%10%20%30%40%50%60%70%80%90%100%WalgreensCVS89%89%Bath&BodyWorksRiteAid85%76%Sephora71%ULTA67%MacCosmeticsTheBodyShopIPSY48%47%43%42%42%BirchboxAmwayMorpheFragranceNet32%31%14Description:With89%each,WalgreensandCVSaretwoofthemostwell-knownbeautyandhealthonlineshopsintheU.S.AnotherAmericanbrand,Bath&BodyWorks,comesthirdinthislistasitisrecognizedby85%ofinternetrespondents.RiteAidclaimsthefourthspotfollowedbySephoraandULTA.ReadmoreNote(s):UnitedStates;JunetoJuly2022;1247respondents;18to64yearsSource(s):ConsumerInsightsCHAPTER
03KeyfiguresofRiteAidTotalrevenueofRiteAidCorporationintheUnitedStatesfrom2012to2023(inbillionU.S.dollars)RevenueoftheRiteAidCorporationintheU.S.2012-20233026.5326.1225.3925.5324.5724.0424.0925201510522.9321.9321.5321.6420.77020122013201420152016*2017*2018*2019*202020212022202316Description:ThisstatisticshowsthetotalrevenueoftheRiteAidCorporationintheUnitedStatesfrom2012to2023.In2023,RiteAidgeneratedabout24.09billionU.S.dollarsintotalrevenue.ReadmoreNote(s):UnitedStates;2012to2023;*Revenuesforthefiscalyearsended.February27,2021,February29,2020,March2,2019,March3,2018,March4,2017andFebruary27,2016exclude$200,326,$232,964and$153,664,respectively,of[...]
ReadmoreSource(s):RiteAidTotalrevenueofRiteAidCorporationintheUnitedStatesfromfiscalyear2017to2023,bysegment(inbillionU.S.dollars)U.S.revenueofRiteAidfrom2017to2023bysegmentRetailpharmacyPharmacyservicesIntersegmenteliminations*302520151057.3217.56.527.976.395.96.096.617.7916.7716.3615.8315.7615.620-0.232017-0.2-0.212019-0.252020-0.292021-0.252022-0.222023-5201817/statistics/1004217/revenue-of-rite-aid-by-segmentThisstatisticshowsthetotalrevenueofRiteAidCorporationintheUnitedStatesfrom2017to2023,brokendownbysegment.Inthefiscalyear2023,theretailpharmacysegmentofRiteAidgeneratednearly17.8billionU.S.dollarsintheUnitedStates.ReadmoreNote(s):UnitedStates;2017to2023;*IntersegmenteliminationsincludeintersegmentrevenuesandcorrespondingcostofrevenuesthatoccurwhenPharmacyServicessegmentcustomersuseRetailPharmacysegmentstorestopurchase[...]
ReadmoreSource(s):RiteAidTotalrevenuegrowthofRiteAidCorporationintheUnitedStatesfrom2014to2023(inbillionU.S.dollars)RevenuegrowthoftheRiteAidCorporationintheU.S.2014-202330%25.4%25%20%15%10.4%9.6%10%3.9%20155%0%2.2%20221.3%20200.5%20140.5%2019-1.9%2023-5%-6.1%2018-10%20162017202118Description:ThisstatisticshowsthetotalrevenuegrowthoftheRiteAidCorporationintheUnitedStatesfrom2014to2023.Inthefinancialyear2023whichendedonMarch4,2023,thecompany'srevenuedeclinedby1.9percent.
ReadmoreNote(s):UnitedStates;2014to2023Source(s):RiteAidTotalrevenueofRiteAidCorporationintheUnitedStatesin2023,byquarter(inbillionU.S.dollars)U.S.revenueofRiteAid2023,byquarter76.086.096.015.96543210Q1Q2Q3Q419Description:ThisstatisticshowsthetotalrevenueofRiteAidCorporationintheUnitedStatesforthefiscalyear2023,byquarter.RiteAidgeneratedabout6.09billionU.S.dollarsinthefourthquarterof2023.ReadmoreNote(s):UnitedStates;2023Source(s):RiteAidGrossprofitofRiteAidCorporationintheUnitedStatesfrom2018to2023(inmillionU.S.dollars)GrossprofitoftheRiteAidCorporationintheU.S.2018-20236,0005,106.55,0004,0003,0002,0001,00004,780.14,726.764,803.944,676.354,704.3220182019202020212022202320Description:TheRiteAidCorporation'sgrossprofitintheUnitedStateswasabout4.8billionU.S.dollarsforthefiscalyearendedMarch4,2023.Thatyear,RiteAidgeneratedabout24.09billionU.S.dollarsintotalrevenue.
ReadmoreNote(s):UnitedStates;2018to2023Source(s):RiteAidSalesshareofRiteAidintheUnitedStatesin2023,byproductclassSalesshareofRiteAidintheU.S.2023,byproductclassHealthandbeautyaids4.3%Over-the-countermedicationsandpersonalcare10.9%Generalmerchandiseandother13.6%Prescriptiondrugs71.2%21Description:ThestatisticdepictsthesalesshareofRiteAidintheUnitedStatesinthefiscalyearendingMarch4,2023,byproductclass.Inthatyear,healthandbeautyaidproductsgeneratedoverfourpercentofRiteAid'ssales.
ReadmoreNote(s):UnitedStates;2023Source(s):RiteAidTotalnumberofstoresofRiteAidintheUnitedStatesfrom2012to2023TotalnumberofstoresofRiteAidintheU.S.2012-20235,0004,6674,6234,5874,5704,5614,5364,5004,0003,5003,0002,5002,0001,5001,0005002,5502,5102,4692,4612,4502,3090201220132014201520162017201820192020202120222023Year22Description:ThestatisticdepictsthetotalnumberofstoresofRiteAidintheUnitedStatesfrom2012to2023.In2023,RiteAidoperated2,309storesthroughouttheUnitedStates,downfrom4,623adecadeagoin2013.
ReadmoreNote(s):UnitedStates;2012to2023Source(s):RiteAidTotalnumberofstoresofRiteAidintheUnitedStatesin2023,bystateNumberofstoresofRiteAidintheU.S.2023,bystateNumberofstores050100150200250300350400450500550PennsylvaniaCaliforniaNewYorkMichigan487477271249Ohio195191WashingtonNewJerseyOregon112686458VirginiaNewHampshireMarylandDelawareConnecticut40373023Description:ThestatisticdepictsthetotalnumberofstoresofRiteAidintheUnitedStatesasofMarch4,2023,bystate.Inthatyear,RiteAidoperated64storesinVirginia.ReadmoreNote(s):UnitedStates;2023Source(s):RiteAidRiteAidbrandawareness,usage,popularity,loyalty,andbuzzamongbeautyandhealthonlineshopusersintheUnitedStatesin2022RiteAidbrandprofileintheUnitedStates202278%80%70%60%50%40%30%20%10%0%22%19%16%15%RiteAidawarenessRiteAidpopularityRiteAidusageRiteAidloyaltyRiteAidbuzz24Description:HowhighisthebrandawarenessofRiteAidintheUnitedStates?ReadmoreNote(s):UnitedStates;15June2022to23June2022;1039respondents;18-64years;respondentswhousebeauty&healthSource(s):ConsumerInsightsRiteAidbrandawareness,usage,popularity,loyalty,andbuzzamongonlinepharmacyusersintheUnitedStatesin2022RiteAidbrandprofileintheUnitedStates202280%80%70%60%50%40%30%20%10%0%36%27%23%21%RiteAidawarenessRiteAidpopularityRiteAidusageRiteAidloyaltyRiteAidbuzz25Description:HowhighisthebrandawarenessofRiteAidintheUnitedStates?ReadmoreNote(s):UnitedStates;15June2022to26July2022;885respondents;18-64years;respondentswhouseonlinepharmaciesSource(s):ConsumerInsightsCHAPTER
04CompetitorsCVSHealth'snetincomefrom2006to2022(inmillionU.S.dollars)CVSHealth'snetincome2006-20229,0008,0007,8987,1926,6236,6317,0006,0005,0004,0003,0002,0001,00005,3195,2374,5924,6444,1653,8643,6903,4243,4623,1982,6231,3552006-1,000-2,000-596200720082009201020112012201320142015201620172018201920202021202227Description:TheCVSHealthCorporationisaU.S.drugretailingcompany,withthreemajorsegments:CVS/pharmacy,CaremarkPharmacyServicesandMinuteClinic.CVSHealthisheadquarteredinWoonsocket,RhodeIsland.In2022,thecompany'snetincomewasrecordedatapproximately4.16billionU.S.dollars.In2014,thecompanychangeditsnamefromCVSCaremarktoCVSHealth.ReadmoreNote(s):UnitedStates;2006to2022Source(s):CVSHealthCVSHealth'srevenuefrom2005to2022(inmillionU.S.dollars)CVSHealth'srevenue2005-2022350,000300,000250,000200,000150,000100,00050,000020052006200720082009201020112012201320142015201620172018201920202021202228Description:Intheyear2022,theCVSHealthCorporationgeneratedapproximately322.5billionU.S.dollarsofrevenueintotal,anincreasecomparedtothepreviousyears.Thisvalueisthehighesteverregisteredintheconsideredtimeframe.
ReadmoreNote(s):UnitedStates;2005to2022Source(s):CVSHealthSalesofWalgreensBootsAllianceworldwidefrom2018to2023,bygeographicalregion(inmillionU.S.dollars)WalgreensBootsAlliancesalesworldwide2018-2023,bygeographicalregionUnitedStatesUnitedKingdomGermany**Other140,000120,000100,00080,00060,00040,00020,000020182019202020212022202329Description:WalgreensBootsAllianceisaUnitedStates-basedpharmacyretailandwholesalecompany,operatingpharmaciesanddrugstores.ThecompanygeneratesagreateramountofitstotalsalesfromtheUnitedStates,withsalesreachingmorethan116billionU.S.dollarsinthisregionin2023.InGermany,thevalueofWalgreens'ssaleswasrecordedasapproximately11.2billionU.S.dollarsin2023.ReadmoreNote(s):Worldwide;2018to2023Source(s):WalgreensRetailpharmacysalesofWalgreensintheUnitedStatesfrom2018to2023,bydivision(inmillionU.S.dollars)WalgreenspharmacyretailsalesintheU.S.2018-2023,bydivisionPharmacyRetail84,89290,00082,11880,48180,43477,19280,00070,00060,00050,00040,00030,00020,00010,000071,05528,64328,19527,33727,34027,22027,11320182019202020212022202330Description:Salesfromitspharmacysegme
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024-2025学年三年级数学下册第三单元乘法教案北师大版
- 2024-2025学年九年级科学下册第3章人的降第1节降作业设计新版浙教版
- 人教版数学七年级上册3.3《解一元一次方程(二)-去括号与去分母》(去括号)听评课记录2
- 保育员个人年度工作总结
- 电视台广告部实习总结
- 设计版权合同范本
- 铺面合伙协议书范本
- 公司商业合作保密协议书范本
- 顶管施工劳务合同范本
- 七年级信息技术上册 数据处理的初相识说课稿
- 《物流市场营销环境》课件
- 泰山英文简介
- 公司组织知识清单范例
- 2023年部编高中语文选择性必修上之海明威的冰山理论和电报体风格
- 网咖成本预算明细表
- 2023年上半年重庆三峡融资担保集团股份限公司招聘6人上岸笔试历年难、易错点考题附带参考答案与详解
- 标志设计 课件
- 金属常见的腐蚀形态及防护措施-课件
- (完整版)客户拜访方案
- 老年病科工作手册
- 医务科运用PDCA循环提高门诊医生准时出诊率PDCA成果汇报
评论
0/150
提交评论